Infinity Pharmaceuticals (INFI)

Add to Watchlists
Create an Alert
15.24 +0.53  +3.60% NASDAQ Nov 26, 8:00PM BATS Real time Currency in USD
View Full Chart
INFI Price Chart
View All Events

INFI Events

Date Type Description
11/06/2014 16:30 EDT Misc Q3 2014 Infinity Pharmaceuticals, Inc. Earnings Conference Call
11/06/2014 Earnings Q3 2014 Infinity Pharmaceuticals, Inc. Earnings Result
08/05/2014 08:30 EDT Misc Q2 2014 Infinity Pharmaceuticals, Inc. Earnings Conference Call
08/05/2014 Earnings Q2 2014 Infinity Pharmaceuticals, Inc. Earnings Result
06/17/2014 Misc Annual General Meeting for Infinity Pharmaceuticals Inc
05/06/2014 16:30 EDT Misc Infinity Pharmaceuticals Inc 1Q2014 Earning Conference Call
05/06/2014 Earnings Infinity Pharmaceuticals Inc 1Q2014 Earning Result
02/25/2014 08:30 EDT Misc Q4 2013 Infinity Conference Call and Webcast
02/04/2014 Earnings Q4 2013 Infinity Earnings Results
View All Performance Charts

INFI Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Infinity Pharmaceuticals is up 4.96% over the last year vs S&P 500 Total Return up 17.38%, AbbVie up 45.92%, and Roche Holding up 10.25%.

Get Quote for
Advertisement

Portfolio Strategies Featuring INFI

Did Infinity Pharmaceuticals make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

INFI Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website: http://www.infi.com
  • IR Website: http://phx.corporate-ir.net/phoenix.zhtml?c=121941&p=irol-irhome
  • HQ Country: United States
  • HQ State/Province: Massachusetts
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: December 31, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: September 30, 2014
  • Last Fiscal Year End: December 31, 2013
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

Infinity Pharmaceuticals, Inc. is a biopharmaceutical company engaged in discovering, developing & delivering medicines to people with difficult-to-treat diseases. Its primary product candidate is IPI-145, an oral inhibitor of phosphoinositide-3-kinase.

INFI Excel Add-In Codes

  • Name: =YCI("INFI","name")
  • Description: =YCI("INFI","description")
  • Sector: =YCI("INFI","sector")
  • Industry: =YCI("INFI","industry")
  • Est. Current Fiscal Year End: =YCI("INFI","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 14-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 14 Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.